Cargando…

In Vitro–In Vivo Correlation of Posaconazole–Amphotericin B Combination against Candida albicans: In Vitro Interacting Concentrations Are Associated with In Vivo Free Drug Levels

The in vitro/in vivo correlation of antifungal combination testing is necessary in order to assess the efficacy of combination regimens. We, therefore, attempted to correlate in vitro chequerboard testing of posaconazole (POS) and amphotericin B (AMB) with the in vivo outcome of combination therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meletiadis, Joseph, Beredaki, Maria-Ioanna, Elefanti, Antigoni, Pournaras, Spyros, Muller, Anouk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146624/ https://www.ncbi.nlm.nih.gov/pubmed/37108889 http://dx.doi.org/10.3390/jof9040434

Ejemplares similares

Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation
por: Siopi, Maria, et al.
Publicado: (2023)

Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans
por: Chen, Ying-Lien, et al.
Publicado: (2013)

Combination of Posaconazole and Amphotericin B in the Treatment of Candida glabrata Biofilms
por: Rodrigues, Célia F., et al.
Publicado: (2018)

In vitro and in vivo Activity of Phibilin Against Candida albicans
por: Li, Zhongjie, et al.
Publicado: (2022)

Application of 460 nm visible light for the elimination of Candida albicans in vitro and in vivo
por: Wang, Chuan, et al.
Publicado: (2018)

In Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans Biofilms
por: Seleem, Dalia, et al.
Publicado: (2016)

Candida albicans Enhances the Progression of Oral Squamous Cell Carcinoma In Vitro and In Vivo
por: Vadovics, Máté, et al.
Publicado: (2022)

Comparative dynamics of gene expression during in vitro and in vivo Candida albicans filamentation
por: Wakade, Rohan S., et al.
Publicado: (2023)

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates
por: de-la-Fuente, Iñigo, et al.
Publicado: (2023)

In Vitro, Ex Vivo, and In Vivo Evaluation of Nanoparticle-Based Topical Formulation Against Candida albicans Infection
por: Sadozai, Sajid Khan, et al.
Publicado: (2022)

Synergistic effect of pyrvinium pamoate and posaconazole against Cryptococcus neoformans in vitro and in vivo
por: Li, Yali, et al.
Publicado: (2022)

Acquisition of cross-azole tolerance and aneuploidy in Candida albicans strains evolved to posaconazole
por: Kukurudz, Rebekah J, et al.
Publicado: (2022)

Nanoemulsion Increases the Antifungal Activity of Amphotericin B against Four Candida auris Clades: In Vitro and In Vivo Assays
por: Marena, Gabriel Davi, et al.
Publicado: (2023)

In vitro and in vivo effects of suloctidil on growth and biofilm formation of the opportunistic fungus Candida albicans
por: Zeng, Beini, et al.
Publicado: (2017)

Biofilm Formation and Susceptibility to Amphotericin B and Fluconazole in Candida albicans
por: Zarei Mahmoudabadi, Ali, et al.
Publicado: (2014)

Modes of the antibiotic activity of amphotericin B against Candida albicans
por: Grela, Ewa, et al.
Publicado: (2019)

Nicotinamide potentiates amphotericin B activity against Candida albicans
por: Yan, Yu, et al.
Publicado: (2022)

Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans
por: Zia, Qamar, et al.
Publicado: (2015)

Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole
por: Firinu, Davide, et al.
Publicado: (2011)

Field Evaluation of the New Rapid NG-Test(®) SARS-CoV-2 Ag for Diagnosis of COVID-19 in the Emergency Department of an Academic Referral Hospital
por: Avgoulea, Kalliopi, et al.
Publicado: (2022)

In vivo and in vitro Pathogenesis and Virulence Factors of Candida albicans Strains Isolated from Cutaneous Candidiasis
por: Sadeghi, Golnar, et al.
Publicado: (2020)

In vitro and in vivo Characterization of Host–Pathogen Interactions of the L3881 Candida albicans Clinical Isolate
por: Sucupira, Pedro H. F., et al.
Publicado: (2022)

Amphotericin-B-liposomal/posaconazole: Mixed transaminitis: case report
Publicado: (2021)

Amphotericin B liposomal/posaconazole: Lack of efficacy: case report
Publicado: (2022)

Recurrent Candida albicans Ventriculitis Treated with Intraventricular Liposomal Amphotericin B
por: Toprak, Demet, et al.
Publicado: (2015)

In Vivo Efficacy of Amphotericin B against Four Candida auris Clades
por: Forgács, Lajos, et al.
Publicado: (2022)

The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus
por: El-Khoury, Moufid, et al.
Publicado: (2017)

In vitro activities of Traganum nudatum and Mentha pulegium extracts combined with amphotericin B against Candida albicans in production of hydrolytic enzymes
por: Tefiani, Ikram, et al.
Publicado: (2020)

Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient
por: Anderson, Anthony, et al.
Publicado: (2017)

Inhibitory Effect of Morin Against Candida albicans Pathogenicity and Virulence Factor Production: An in vitro and in vivo Approaches
por: Abirami, Gurusamy, et al.
Publicado: (2020)

Molecular Epidemiology and Antifungal Susceptibility of Trichophyton Isolates in Greece: Emergence of Terbinafine-Resistant Trichophyton mentagrophytes Type VIII Locally and Globally
por: Siopi, Maria, et al.
Publicado: (2021)

In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia
por: Gheith, Soukeina, et al.
Publicado: (2014)

Synergistic effect of terbinafine and amphotericin B in killing Fonsecaea nubica in vitro and in vivo
por: Zhang, Jing, et al.
Publicado: (2019)

Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review
por: Bezerra, Lucas Soares, et al.
Publicado: (2020)

Calcium-Activated-Calcineurin Reduces the In Vitro and In Vivo Sensitivity of Fluconazole to Candida albicans via Rta2p
por: Jia, Yu, et al.
Publicado: (2012)

Gallic acid/hydroxypropyl-β-cyclodextrin complex: Improving solubility for application on in vitro/ in vivo Candida albicans biofilms
por: Teodoro, Guilherme Rodrigues, et al.
Publicado: (2017)

Antifungal Activity of the Biphosphinic Cyclopalladate C7a against Candida albicans Yeast Forms In Vitro and In Vivo
por: Muñoz, Julian E., et al.
Publicado: (2017)

The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo
por: Antoran, Aitziber, et al.
Publicado: (2020)

Intravital Imaging of Candida albicans Identifies Differential In Vitro and In Vivo Filamentation Phenotypes for Transcription Factor Deletion Mutants
por: Wakade, Rohan S., et al.
Publicado: (2021)

Evaluation of the in vitro Activity and in vivo Efficacy of Anidulafungin-Loaded Human Serum Albumin Nanoparticles Against Candida albicans
por: Zhang, Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4qp71bgll9hdojn3gfgt7d2bs9